Molecular characterization ofde novoPhiladelphia chromosome-positive acute myeloid leukemia

BCR-ABL kinase domain mutation analysis in chronic myeloid leukemia patients treated with tyrosine kinase inhibitors: recommendations from an expert panel on behalf of European LeukemiaNet

(2011) S. Soverini et al.   BLOOD

Subclones with the t(9;22)/BCR-ABL1 rearrangement occur in AML and seem to cooperate with distinct genetic alterations

(2011) Ulrike Bacher et al.   BRITISH JOURNAL OF HAEMATOLOGY

Discontinuation of imatinib may be possible in chronic myelogenous leukemia

(2011) Mary Kay Barton   CA-A CANCER JOURNAL FOR CLINICIANS

Diagnostic Testing for IDH1 and IDH2 Variants in Acute Myeloid Leukemia

(2011) Keyur P. Patel et al.   JOURNAL OF MOLECULAR DIAGNOSTICS

Mutation analysis of TET2, IDH1, IDH2 and ASXL1 in chronic myeloid leukemia

(2011) C Roche-Lestienne et al.   LEUKEMIA

A deep-sequencing study of chronic myeloid leukemia patients in blast crisis (BC-CML) detects mutations in 76.9% of cases

(2011) V Grossmann et al.   LEUKEMIA

Rapid clonal shifts in response to kinase inhibitor therapy in chronic myelogenous leukemia are identified by quantitation mutation assays

(2010) C. Cameron Yin et al.   CANCER SCIENCE

IDH1andIDH2Gene Mutations Identify Novel Molecular Subsets Within De Novo Cytogenetically Normal Acute Myeloid Leukemia: A Cancer and Leukemia Group B Study

(2010) Guido Marcucci et al.   JOURNAL OF CLINICAL ONCOLOGY

IDH1 and IDH2 Mutations Are Frequent Genetic Alterations in Acute Myeloid Leukemia and Confer Adverse Prognosis in Cytogenetically Normal Acute Myeloid Leukemia With NPM1 Mutation Without FLT3 Internal Tandem Duplication

(2010) Peter Paschka et al.   JOURNAL OF CLINICAL ONCOLOGY

IDH2 somatic mutations in chronic myeloid leukemia patients in blast crisis

(2010) S Soverini et al.   LEUKEMIA

The 2008 revision of the World Health Organization (WHO) classification of myeloid neoplasms and acute leukemia: rationale and important changes

(2009) J. W. Vardiman et al.   BLOOD

Cytoplasmic mutated nucleophosmin (NPM1) in blast crisis of chronic myeloid leukaemia

(2009) P P Piccaluga et al.   LEUKEMIA